Financial Statements — LIMNW
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Cash & Equivalents | -- | -- | -- | -- | 0.00 |
| Total Current Assets | 3.39 | 2.78 | 1.20 | 1.78 | -- |
| Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.00 | -- |
| Total Non-current Assets | 0.01 | 0.01 | 0.14 | 0.13 | -- |
| Total Assets | 3.40 | 2.79 | 1.34 | 1.91 | -- |
| Accounts Payable | 0.66 | 0.53 | 0.56 | 0.43 | -- |
| Short-term Debt | 1.44 | 1.44 | 1.44 | 1.44 | -- |
| Total Current Liabilities | 3.04 | 2.89 | 2.86 | 10.52 | -- |
| Total Non-current Liabilities* | 0.06 | 0.03 | 0.12 | 0.20 | -- |
| Total Liabilities | 3.10 | 2.92 | 2.99 | 10.72 | 0.00 |
| Retained Earnings | (41.40) | (40.00) | (30.70) | (28.88) | -0.00 |
| Total Stockholder Equity | 0.30 | (0.13) | (1.65) | (8.81) | -0.00 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Research & Development | 0.60 | 0.40 | 0.00 | 0.36 | 0.71 | -- |
| Selling, General & Admin | 0.78 | 0.70 | 0.88 | 0.70 | 1.12 | -- |
| Total Operating Expenses | 1.38 | 1.10 | 0.88 | 0.70 | 1.12 | -- |
| Operating Income | (1.38) | (1.10) | (1.15) | (0.70) | (1.12) | -0.00 |
| Net Income | (1.41) | (1.12) | (8.50) | (1.82) | 0.11 | -0.00 |
| Basic EPS | (0.03) | (0.03) | 2.19 | (0.07) | 0.00 | (2.55) |
| Diluted EPS | (0.03) | (0.03) | 2.19 | (0.07) | 0.00 | (2.55) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Operating Cash Flow | (0.97) | (2.02) | (0.39) | (0.60) | (8.98) | 0.00 |
| Capital Expenditures | -- | -- | -- | 0.01 | -- | -- |
| Free Cash Flow* | -- | -- | -- | (0.61) | -- | -- |
| Investing Cash Flow | -- | (0.57) | 0.00 | (0.01) | (0.77) | -- |
| Financing Cash Flow | 2.08 | 3.59 | 0.00 | 0.00 | 11.03 | -- |
* Derived from reported values